Navigation Links
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
Date:4/25/2009

rial of Albuferon (Zeuzem S, et al), click here. To view the EASL oral presentation reporting results of the ACHIEVE 2/3 clinical trial of Albuferon (Nelson D, et al), click here. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com This e-mail address is being protected from spam bots, you need JavaScript enabled to view it or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual pro
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
2. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. First Human Study to Show Sun Chlorella A Supports Heart Health
5. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
6. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
7. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
8. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
9. Drug Development Program Started Based on CAP(R) Human Cell Line
10. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
11. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... YORK and LONDON , ...   FDNA Inc. ( http://www.fdna.com ) and ... that they have partnered to offer, for the first ... through FDNA,s solutions. FDNA, developer of the ... integrate LMD,s award-winning collection into Face2Gene [ TM ...
(Date:8/26/2014)... -- Based on its recent analysis of the breast imaging solutions ... North American Frost & Sullivan Award for Technology Innovation Leadership. ... solutions for the early detection of breast cancer. Over the ... solutions and has expanded its global reach to cover ... , Asia and Australia ...
(Date:8/26/2014)... , Aug. 26, 2014 Novira Therapeutics, ... for curative treatment of chronic hepatitis B virus (HBV) ... M.D., F.A.C.P., was appointed the Chair of its Scientific ... function as a Senior Advisor to the Company.  ... our SAB as Chair," said Christian Schade , ...
Breaking Medicine Technology:FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... 2011 Advanced Cell Diagnostics (ACD), a technological ... provider for biomedical image and data analysis, announce ... applications that will enable researchers to accurately quantify ... clinical specimen. The partnership will build on ACD,s ...
... 31, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... Phase IIb/III clinical trial of tasimelteon in patients with ... begin during the second half of 2011.  Tasimelteon is ... the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind ...
Cached Medicine Technology:Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis 2Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis 3Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression 2Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression 3Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression 4
(Date:8/27/2014)... 2014 The use of ESAs to ... and may eliminate the need for blood transfusion and ... AllMed webinar, Dr. Zanhua Yi, board certified in hematology, ... medical necessity of erythropoiesis-stimulating agents (ESAs) in the treatment ... U.S. Food and Drug Administration (FDA) has approved three ...
(Date:8/27/2014)... Janice Holly Booth didn’t choose to travel ... her on an adventure outing to southern Utah where she’d ... harnesses and rappelling into mysterious, dark and potentially dangerous canyons. ... not my last,” she says. “I travelled alone for more ... edge, and experienced first-hand the kind of fear that keeps ...
(Date:8/27/2014)... The Connecticut Community for Addiction Recovery (CCAR) ... 2014, from 10:00 AM – 2:00 PM in Bushnell Park ... participants across the state to show their support for recovery ... state capitol. , Recovery Walks! is a celebration for the ... and other drugs as well as their families, friends, and ...
(Date:8/26/2014)... August 27, 2014 Hearing aids ... be hard for plan holders to determine what their hearing ... participating in several additional health plans and has published benefit ... assistance page . , The following is a list ... a participating provider: , NYSHIP/ NYS Empire Plan - Hearing ...
(Date:8/26/2014)... Emerging and established leaders who want to ... they serve – which includes their subordinates – should ... and read his latest must-read blog post titled ... , “Leadership is not a static role ... assumed,” commented Per Wickstrom, who blogs regularly on a ...
Breaking Medicine News(10 mins):Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Per Wickstrom’s Latest Blog Post Provides 10 Tips to Help Leaders Maintain their Edge 2
... Across Nation Using Caregiverlist.com to Find Quality ... ... the nation,s online,destination dedicated to connecting seniors with quality senior care,choices, ... senior,in-home care services as the caregiving recruitment source for the,industry. Nearly ...
... are turning their attention to the normal cells that ... tumor growth might be stopped at the earliest opportunity. ... come from can provide critical insight into how cancers ... and Cancer Biology at Duke University Medical Center. "This ...
... aggressive childhood brain tumor known as medulloblastoma originates in ... on by a known mutant, cancer-causing oncogene, say researchers ... San Francisco (UCSF). , Reporting in the Aug. 12 ... they have uncovered new origins for these tumors from ...
... Medical receives Governor,s 2008 Excellence in Exporting Award (,E-Award,), official state ... Lieutenant Governor Lee Fisher present award to CSZ Chairman of the ... ... 2008 -- Cincinnati Sub-Zero (CSZ) Medical, a division of CSZ Products, ...
... In one of the first examinations of PSA screening in ... Prostate Center finds that one-fifth of men under age 50 ... prostate cancer in the previous year, yet only one in ... in the previous year. , Overall, that,s pretty good ...
... LANSING, Mich. The health of people who never ... counterparts, according to new research that suggests the practice ... , Hui Liu, assistant professor of sociology at Michigan ... sociologists since the 1970s have emphasized that marriage benefits ...
Cached Medicine News:Health News:Home Care Agencies Staffing Challenge Solved With Caregiverlist.com 2Health News:Key to treating cancer may be finding its original cell 2Health News:Childhood brain tumor traced to normal stem cells gone bad 2Health News:Childhood brain tumor traced to normal stem cells gone bad 3Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 2Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 3Health News:Study finds more PSA screening awareness needed among high-risk groups 2Health News:Health and marriage: The times they are a changin' 2
The three point staple, used for valgus tibial osteotomy, is easy and quick to fit, with a compact size compared with other existing systems....
The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
... Radiopaque Bone Cement consists of ... sterile,ampule containing bone cement liquid ... a sterile polyethylene bag,containing bone ... pouch. The interiors of the ...
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Medicine Products: